Mark Anthony McCamish - Director at Avadel Pharmaceuticals Plc

Insider Transactions and Holdings

Entity Type
Individual
Role
Director
Stock Symbol
AVDL on Nasdaq
All Insider Reports
All Insider Reports

Mark Anthony McCamish - trading volume in the past year for Avadel Pharmaceuticals Plc

Holdings reported by Mark Anthony McCamish for Avadel Pharmaceuticals Plc

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
ADSs 67K $972K $14.50 Dec 28, 2023 By Matthew 5 LLC
Ordinary Shares 67K Jul 30, 2024 By Matthew 5 LLC
Ordinary Shares 11K Jul 30, 2024 Direct
Stock Option (Right to Buy) 11K Jul 30, 2024 Direct Ordinary Shares

Transactions reported by Mark Anthony McCamish for Avadel Pharmaceuticals Plc

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.